KRMD KORU Medical: Company Value to Revenue

KORU Medical Systems dominates the home subcutaneous drug delivery systems segment via its Freedom platform. The enterprise value-to-revenue dynamics demonstrate market expectations, where 3141.34 reflects the latest metric value. Growth is supported by the relevance of devices for immunodeficiency therapy, while sustainable margins are ensured through diversified consumables logistics and reliable supply channels.
KRMD (KORU Medical Systems, Inc.): analytical breakdowns and indicator data

This indicator determines the market value of the business, accounting for net debt relative to sales volume. By analyzing the EV-to-revenue ratio, an investor assesses the company's scaling efficiency. For KORU Medical Systems (KRMD), this metric reflects the capitalization of high-tech facilities in New York. Production automation and strict polymer control establish a foundation for stable growth. A high value for this indicator confirms the asset's reliability when attracting investment.